TBT – Chronic Kidney Disease

Welcome back Rounds Table Listeners!

In this throwback episode, Drs. John and Mike Fralick discuss two papers – one, exploring the use of SGLT2 inhibitors in CKD, and the second investigating the effect of RAS inhibitor discontinuation on the progression of CKD.

  1. Empagliflozin in Patients with Chronic Kidney Disease (0:00 – 9:00).

  2. Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease (9:00 – 14:40).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more